Stocks and InvestingStocks and Investing
Tue, April 10, 2018
Mon, April 9, 2018
Fri, April 6, 2018
Thu, April 5, 2018
Wed, April 4, 2018
Tue, April 3, 2018
Mon, April 2, 2018
Thu, March 29, 2018
Wed, March 28, 2018

Etzer Darout Maintained (ACRS) at Buy with Decreased Target to $52 on, Mar 28th, 2018


Published on 2024-10-26 04:09:23 - WOPRAI, Etzer Darout
  Print publication without navigation


Etzer Darout of Leerink Swann, Maintained "Aclaris Therapeutics, Inc." (ACRS) at Buy with Decreased Target from $54 to $52 on, Mar 28th, 2018.

Etzer has made no other calls on ACRS in the last 4 months.



There is 1 other peer that has a rating on ACRS. Out of the 1 peers that are also analyzing ACRS, 0 agree with Etzer's Rating of Hold.



This is the rating of the analyst that currently disagrees with Etzer


  • Seamus Fernandez of "Leerink Swann" Maintained at Buy with Decreased Target to $54 on, Tuesday, March 13th, 2018